News

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 50

60 Minutes Australia features Patient 71, Julie Randall, and Providence Cancer Center

July 10, 2017

With the release of her book Patient 71, Australia native Julie Randall has given cancer patients across the globe hope for life after cancer. Her remarkable story of overcoming stage IV metastatic melanoma was featured in a segment by 60 Minutes Australia chronicling her shocking diagnosis, promise to her family and determination to become “Patient 71” in an immunotherapy clinical trial at Providence Cancer Center.

Julie Randall shares about life after cancer at Providence Creating Hope Dinner

June 30, 2017

Known as "Patient 71," persistence paid off for Australian cancer patient Julie Randall Learn more about her story › She now devotes her...

Members of the Earle A. Chiles Research Institute Garner Spotlight of ASCO and National Media

June 21, 2017

The Earle A. Chiles Research Institute, a division of Providence Cancer Center in Portland, Ore., was well-represented at the 2017 annual meeting of the American Society of Clinical Oncology held June 2-6 in Chicago, Ill. 

National Cancer Institute scientist joins Providence, honored nationally for unique and promising Immunotherapy research

May 04, 2017

It has been a busy and exciting start to 2017 for immunotherapy researcher Eric Tran, Ph.D., and it could make a great difference in the lives of people fighting cancer.

Targeted therapy and immunotherapy studies for people with lung cancer

February 22, 2017

More than 20 studies of promising new therapies for lung cancer patients are open now at Providence Cancer Center, including studies of targeted therapies and novel immunotherapy combinations.

Combination Immunotherapy with Galectin-3 Inhibitor GR-MD-02 Enhances Effects in Pre-clinical Models and Early Results of Phase 1 Clinical Trials

February 07, 2017

First-in-human data presented at GTCBio 9th Immunotherapeutics & Immunomonitoring Conference NORCROSS, Ga....

Immunotherapy for Breast Cancer

January 27, 2017

Immunotherapy is a treatment approach that harnesses the immune system to recognize, attack and eliminate cancer. The opportunity to conduct...

Phase I Research at Providence Cancer Center

December 23, 2016

Patients with a variety of cancer types are eligible to receive new and promising treatments when they participate in Phase I research studies at Providence Cancer Center.

Melanoma Research

December 02, 2016

Providence physicians and scientists have been leading the way in melanoma research and treatment for more than 20 years. Our findings have resulted in new ways to boost immune response, which has improved the standard of care for patients with this aggressive malignancy. 

Oral, head and neck cancer research at Providence Cancer Center

October 21, 2016

Providence Oral, Head and Neck Cancer Clinic offers world-class care for patients with benign and malignant tumors of the oral cavity (mouth), tongue, pharynx (throat), larynx (voice box), nose, paranasal sinuses, salivary glands and thyroid gland, as well as tumors at the skull base. Our medical and surgical oncology teams work collaboratively to start patients on treatment regimens very quickly. 

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 50